155 related articles for article (PubMed ID: 20495655)
21. Preoperative high level of D-dimers predicts unresectability of pancreatic head cancer.
Durczynski A; Kumor A; Hogendorf P; Szymanski D; Grzelak P; Strzelczyk J
World J Gastroenterol; 2014 Sep; 20(36):13167-71. PubMed ID: 25278712
[TBL] [Abstract][Full Text] [Related]
22. Malignant intraductal papillary mucinous neoplasm of the pancreas: in situ versus invasive carcinoma surgical resectability.
Vullierme MP; Giraud-Cohen M; Hammel P; Sauvanet A; Couvelard A; O'Toole D; Levy P; Ruszniewski P; Vilgrain V
Radiology; 2007 Nov; 245(2):483-90. PubMed ID: 17848678
[TBL] [Abstract][Full Text] [Related]
23. Prediction of Vascular Invasion Using a 3-Point Scale Computed Tomography Grading System in Pancreatic Ductal Adenocarcinoma: Correlation With Surgery.
Zhang L; Zhang ZY; Ni JM; Li B; Chen FM; Jiang CJ; Hu CH
J Comput Assist Tomogr; 2017; 41(3):394-400. PubMed ID: 27798447
[TBL] [Abstract][Full Text] [Related]
24. Surgery after FOLFIRINOX treatment for locally advanced and borderline resectable pancreatic cancer: increase in tumour attenuation on CT correlates with R0 resection.
Marchegiani G; Todaro V; Boninsegna E; Negrelli R; Sureka B; Bonamini D; Salvia R; Manfredi R; Pozzi Mucelli R; Bassi C
Eur Radiol; 2018 Oct; 28(10):4265-4273. PubMed ID: 29679211
[TBL] [Abstract][Full Text] [Related]
25. Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer.
Ferrone CR; Marchegiani G; Hong TS; Ryan DP; Deshpande V; McDonnell EI; Sabbatino F; Santos DD; Allen JN; Blaszkowsky LS; Clark JW; Faris JE; Goyal L; Kwak EL; Murphy JE; Ting DT; Wo JY; Zhu AX; Warshaw AL; Lillemoe KD; Fernández-del Castillo C
Ann Surg; 2015 Jan; 261(1):12-7. PubMed ID: 25599322
[TBL] [Abstract][Full Text] [Related]
26. Vascular invasion in pancreatic cancer: Imaging modalities, preoperative diagnosis and surgical management.
Buchs NC; Chilcott M; Poletti PA; Buhler LH; Morel P
World J Gastroenterol; 2010 Feb; 16(7):818-31. PubMed ID: 20143460
[TBL] [Abstract][Full Text] [Related]
27. Hepatectomy and pancreatectomy with combined vascular resection in patients with hepato-biliary and pancreas diseases at a single cancer institute.
Nanashima A; Yamaguchi H; Sumida Y; Abo T; Tobinaga S; Tanaka K; Takeshita H; Hidaka S; Sawai T; Yasutake T; Nagayasu T
Hepatogastroenterology; 2008; 55(84):873-8. PubMed ID: 18705286
[TBL] [Abstract][Full Text] [Related]
28. Adenocarcinoma of the head of the pancreas: determination of surgical unresectability with thin-section pancreatic-phase helical CT.
O'Malley ME; Boland GW; Wood BJ; Fernandez-del Castillo C; Warshaw AL; Mueller PR
AJR Am J Roentgenol; 1999 Dec; 173(6):1513-8. PubMed ID: 10584794
[TBL] [Abstract][Full Text] [Related]
29. Role of endoscopic ultrasound and magnetic resonance imaging in the preoperative staging of pancreatic adenocarcinoma.
Ahmad NA; Lewis JD; Siegelman ES; Rosato EF; Ginsberg GG; Kochman ML
Am J Gastroenterol; 2000 Aug; 95(8):1926-31. PubMed ID: 10950037
[TBL] [Abstract][Full Text] [Related]
30. Dual-phase helical CT of pancreatic adenocarcinoma: assessment of resectability before surgery.
Valls C; Andía E; Sanchez A; Fabregat J; Pozuelo O; Quintero JC; Serrano T; Garcia-Borobia F; Jorba R
AJR Am J Roentgenol; 2002 Apr; 178(4):821-6. PubMed ID: 11906855
[TBL] [Abstract][Full Text] [Related]
31. Pancreatic Cancer CT: Prediction of Resectability according to NCCN Criteria.
Hong SB; Lee SS; Kim JH; Kim HJ; Byun JH; Hong SM; Song KB; Kim SC
Radiology; 2018 Dec; 289(3):710-718. PubMed ID: 30251929
[TBL] [Abstract][Full Text] [Related]
32. Palliative pancreaticoduodenectomy in pancreatic and periampullary adenocarcinomas.
Wang SE; Shyr YM; Su CH; Chen TH; Wu CW
Pancreas; 2012 Aug; 41(6):882-7. PubMed ID: 22286381
[TBL] [Abstract][Full Text] [Related]
33. Combined pancreas and liver therapies: resection and ablation in hepato-pancreatico-biliary malignancies.
Edwards J; Scoggins C; McMasters K; Martin R
J Surg Oncol; 2013 Jun; 107(7):709-12. PubMed ID: 23335109
[TBL] [Abstract][Full Text] [Related]
34. Predicting patient survival after pancreaticoduodenectomy for malignancy: histopathological criteria based on perineural infiltration and lymphovascular invasion.
Chen JW; Bhandari M; Astill DS; Wilson TG; Kow L; Brooke-Smith M; Toouli J; Padbury RT
HPB (Oxford); 2010 Mar; 12(2):101-8. PubMed ID: 20495653
[TBL] [Abstract][Full Text] [Related]
35. Validation of at least 1 mm as cut-off for resection margins for pancreatic adenocarcinoma of the body and tail.
Hank T; Hinz U; Tarantino I; Kaiser J; Niesen W; Bergmann F; Hackert T; Büchler MW; Strobel O
Br J Surg; 2018 Aug; 105(9):1171-1181. PubMed ID: 29738626
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis and staging of pancreatic adenocarcinoma with dynamic computed tomography.
Freeny PC; Traverso LW; Ryan JA
Am J Surg; 1993 May; 165(5):600-6. PubMed ID: 8488945
[TBL] [Abstract][Full Text] [Related]
37. Radiologic staging of pancreatic adenocarcinoma.
Nghiem HV; Freeny PC
Radiol Clin North Am; 1994 Jan; 32(1):71-9. PubMed ID: 8284362
[TBL] [Abstract][Full Text] [Related]
38. Does the surgical waiting list affect pathological and survival outcome in resectable pancreatic ductal adenocarcinoma?
Marchegiani G; Andrianello S; Perri G; Secchettin E; Maggino L; Malleo G; Bassi C; Salvia R
HPB (Oxford); 2018 May; 20(5):411-417. PubMed ID: 29191689
[TBL] [Abstract][Full Text] [Related]
39. Preoperative computed tomography measurements of pancreatic steatosis and visceral fat: prognostic markers for dissemination and lethality of pancreatic adenocarcinoma.
Mathur A; Hernandez J; Shaheen F; Shroff M; Dahal S; Morton C; Farrior T; Kedar R; Rosemurgy A
HPB (Oxford); 2011 Jun; 13(6):404-10. PubMed ID: 21609373
[TBL] [Abstract][Full Text] [Related]
40. Is peritoneal cytology a predictor of unresectability in pancreatic carcinoma?
Schmidt J; Fraunhofer S; Fleisch M; Zirngibl H
Hepatogastroenterology; 2004; 51(60):1827-31. PubMed ID: 15532836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
